XML 57 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shareholders' Equity
3 Months Ended
Mar. 31, 2014
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Shareholders' Equity

5. Shareholders’ Equity

Stock Options

We have a stock plan (the “Stock Plan”) and an inducement stock plan for newly hired employees (the “Inducement Plan”) (collectively the “Plans”). Under the Plans, stock options may be granted with a fixed exercise price that is equivalent to fair market value on the date of grant. These options have a term of up to 10 years and vest over a predetermined period, generally four years. Incentive stock options granted under the Stock Plan may only be granted to our employees. The Plans also allow for awards of non-qualified stock options, stock appreciation rights, RSAs and unrestricted stock awards, and RSUs

Stock-Based Compensation

The estimated fair value of stock-based awards is recognized as compensation expense over the vesting period of the awards, net of estimated forfeitures. We estimate forfeitures based on historical experience and expected future activity. The fair value of RSAs and RSUs is determined based on the number of shares granted and the quoted price of our common stock on the date of grant. The fair value of stock option awards is estimated at the grant date based on the fair value of each vesting tranche as calculated by the Black-Scholes-Merton (“BSM”) option-pricing model. The BSM model requires various highly judgmental assumptions including expected volatility and option life. If any of the assumptions used in the BSM model change significantly, stock-based compensation expense may differ materially in the future from that recorded in the current period. The fair values of our stock option grants were estimated with the following weighted average assumptions:

 

     Three Months Ended
March 31,
 
     2014     2013  

Dividend yield

     0     0

Expected life

     3.2 years        3.7 years   

Expected volatility

     61     68

Risk-free interest rate

     1.2     0.6

Stock-based compensation expense for the three months ended March 31, 2014 and 2013 was as follows (in thousands, except per share amounts):

 

     Three Months Ended
March 31,
 
     2014      2013  

Cost of revenue — service

   $ 41       $ 73   

Selling, general and administrative

     175         149   

Research and development

     28         30   
  

 

 

    

 

 

 

Total stock-based compensation expense

   $ 244       $ 252   
  

 

 

    

 

 

 

Per basic and diluted share

   $ 0.02       $ 0.02   
  

 

 

    

 

 

 

 

Stock Option Activity

The following table summarizes stock option activity for the three months ended March 31, 2014:

 

Stock Options

   Number of
Shares
    Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual
Life
(in years)
     Aggregate
Intrinsic
Value
 

Balance at January 1, 2014

     1,515,621      $ 3.36         

Granted at fair value

     330,850        3.32         

Exercised

     (123,613     2.48         

Forfeited

     (12,959     3.64         

Expired

     (57,032     5.92         
  

 

 

         

Balance at March 31, 2014

     1,652,867      $ 3.33         4.91       $ 444,091   
  

 

 

   

 

 

    

 

 

    

 

 

 

Vested and expected to vest at March 31, 2014

     1,561,427      $ 3.33         4.69       $ 444,151   
  

 

 

   

 

 

    

 

 

    

 

 

 

Exercisable at March 31, 2014

     983,478      $ 3.30         2.57       $ 398,709   
  

 

 

   

 

 

    

 

 

    

 

 

 

At March 31, 2014, total compensation cost related to stock options granted but not yet recognized was $708,242, net of estimated forfeitures. This cost will be amortized on the straight-line method over a weighted-average period of approximately 1.5 years.

The following table summarizes certain information about stock options for the three months ended March 31, 2014 and 2013:

 

     Three Months Ended
March 31,
 
     2014      2013  

Weighted-average grant-date fair value of option grants for the period

   $ 1.82      $ 1.65   
  

 

 

    

 

 

 

Options in-the-money at period end

     585,885         615,419   
  

 

 

    

 

 

 

Aggregate intrinsic value of options exercised

   $ 130,876       $ 1,000   
  

 

 

    

 

 

 

The aggregate intrinsic value represents the difference between the exercise price of the underlying options and the quoted price of our common stock for the number of options that were in-the-money at period end or that were exercised during the period. We issue new shares of common stock upon exercise of stock options.

 

Restricted Stock Unit Activity

The following table summarizes RSU activity for the three months ended March 31, 2014:

 

     Number of
Shares
    Weighted Average
Grant Date Fair
Value
 

Unvested at December 31, 2013

     187,382      $ 4.40   

Granted

     15,000        3.34   

Vested

     (52,858     4.17   

Forfeited

     (23,125     5.60   
  

 

 

   

 

 

 

Unvested at March 31, 2014

     126,399      $ 4.16   
  

 

 

   

 

 

 

Expected to vest after March 31, 2014

     120,556      $ 4.02   
  

 

 

   

 

 

 

At March 31, 2014, total compensation cost related to RSUs granted but not yet recognized was $412,570, net of estimated forfeitures. This cost will be amortized on the straight-line method over a period of approximately 1.3 years.

Common Stock Reserved for Future Issuance

The following table summarizes our shares of common stock reserved for future issuance under the Plans at March 31, 2014:

 

     March 31,
2014
 

Stock options outstanding

     1,652,867   

Restricted stock units outstanding

     126,399   

Stock options available for future grant

     884,578   
  

 

 

 

Common stock reserved for future issuance

     2,663,844